Business Description
Inbiogen
ISIN : KR7101140002
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.35 | |||||
Equity-to-Asset | 0.99 | |||||
Debt-to-EBITDA | 0.08 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 17.51 | |||||
Beneish M-Score | -2.22 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -47.1 | |||||
3-Year EPS without NRI Growth Rate | 61.5 | |||||
3-Year FCF Growth Rate | 66.6 | |||||
3-Year Book Growth Rate | -21.6 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.27 | |||||
Quick Ratio | 4.76 | |||||
Cash Ratio | 2.82 | |||||
Days Inventory | 106.23 | |||||
Days Sales Outstanding | 299.53 | |||||
Days Payable | 24.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -58.1 | |||||
Shareholder Yield % | 3.43 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 15.46 | |||||
Operating Margin % | -113.58 | |||||
Net Margin % | 120.48 | |||||
FCF Margin % | -17.95 | |||||
ROE % | 3.91 | |||||
ROA % | 3.83 | |||||
ROIC % | -3.4 | |||||
3-Year ROIIC % | -0.69 | |||||
ROC (Joel Greenblatt) % | 92.93 | |||||
ROCE % | 3.87 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 21.08 | |||||
PE Ratio without NRI | 17.81 | |||||
Price-to-Owner-Earnings | 11.88 | |||||
PS Ratio | 18.97 | |||||
PB Ratio | 0.6 | |||||
Price-to-Tangible-Book | 0.61 | |||||
EV-to-EBIT | 9.9 | |||||
EV-to-EBITDA | 8.24 | |||||
EV-to-Revenue | 11.89 | |||||
EV-to-FCF | -66.21 | |||||
Price-to-Projected-FCF | 1.39 | |||||
Price-to-Median-PS-Value | 2.85 | |||||
Price-to-Graham-Number | 0.69 | |||||
Price-to-Net-Current-Asset-Value | 12.84 | |||||
Price-to-Net-Cash | 33.11 | |||||
Earnings Yield (Greenblatt) % | 10.1 | |||||
FCF Yield % | -1.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Inbiogen Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 4,918.863 | ||
EPS (TTM) (â‚©) | 443 | ||
Beta | 1.31 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (â‚©) | 0 | ||
20-Day SMA (â‚©) | 9340 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (â‚©) | 9340 - 9340 | ||
Shares Outstanding (Mil) | 9.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Inbiogen Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Inbiogen Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Inbiogen Frequently Asked Questions
What is Inbiogen(XKRX:101140)'s stock price today?
When is next earnings date of Inbiogen(XKRX:101140)?
Does Inbiogen(XKRX:101140) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |